Global Human Papilloma Virus (HPV) Vaccine Market
The human papilloma virus (HPV) vaccine market is projected to witness a compound annual growth rate of 8.51% to grow to US$4,481.480 million by 2026, from US$2,529.765 million in 2019. According to the WHO guidelines, routine vaccination is recommended to all countries along with other vaccinations. Human Papilloma Virus (HPV) Vaccine protects from certain types of Human Papilloma Viruses that can lead to cancer or genital warts. According to the WHO guidelines, routine vaccination is recommended to all countries along with other vaccinations. These vaccines are on the “World Health Organisation’s list of Essential Medicines” and are considered safe and effective medicines.
The market for the global Human Papilloma Virus (HPV) Vaccine is augmented by the increasing number of Cervical Cancer cases worldwide. Rising awareness regarding cervical cancer and HPV owing to the number of initiatives by the governments will also boost the market for the HPV vaccines. However, a strict regulatory approval process for the vaccines might restrain the growth of the market during the given time frame.
The Global Human Papilloma Virus (HPV) Vaccine Market – Forecasts from 2021 to 2026” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key markets, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, indication, gender, and geography.
Based on type, the market has been segmented as Quadrivalent HPV Vaccine and Bivalent HPV Vaccine. On the basis of indication, the market is divided into Cervical Cancer, Anal Cancer, Vaginal Cancer, Vulvar Cancer, Mouth Cancer, and Genital Warts. The market is divided into Girls and Boys on the basis of Gender.
Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, the Middle East and Africa, and Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the Human Papilloma Virus (HPV) Vaccine market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the Human Papilloma Virus (HPV) Vaccine market.
Segmentation:
By Type
Quadrivalent HPV Vaccine
Bivalent HPV Vaccine
9-Valent HPV Vaccine
By Indication
Cervical Cancer
Anal Cancer
Vaginal Cancer
Vulvar Cancer
Mouth Cancer
Genital Warts
By Gender
Male
Female
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
UK
Germany
Italy
Spain
Others
Middle East and Africa (MEA)
Israel
Saudi Arabia
Others
Asia Pacific (APAC)
China
Japan
India
Australia
Others
- 1. INTRODUCTION
- 1.1. Market Overview
- 1.2. Covid-19 Scenario
- 1.3. Market Definition
- 1.3. Scope of the Study
- 1.5. Currency
- 1.6. Assumptions
- 1.7. Base, and Forecast Years Timeline
- 2. RESEARCH METHODOLOGY
- 2.1. Research Design
- 2.2. Secondary Sources
- 2.3. Validation
- 3. KEY FINDINGS
- 4. MARKET DYNAMICS
- 4.1. Segmentation
- 4.2. Drivers
- 4.2.1. Growing Cases of HPV Associated Cancers
- 4.2.2. Initiatives by Governments and Organizations
- 4.3. Restraints
- 4.3.1. Strict Process for Regulatory Approval
- 4.4. Porter’s Five Forces Analysis
- 4.4.1. Bargaining Power of Suppliers
- 4.4.2. Bargaining Power of Buyers
- 4.4.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.4.5. Competitive Rivalry in the Industry
- 4.5. Industry Value Chain Analysis
- 5. HUMAN PAPILLOMA VIRUS VACCINE MARKET BY TYPE
- 5.1. Introduction
- 5.2. Quadrivalent HPV Vaccine
- 5.3. Bivalent HPV Vaccine
- 5.4. 9-Valent HPV Vaccine
- 6. HUMAN PAPILLOMA VIRUS VACCINE MARKET BY INDICATION
- 6.1. Introduction
- 6.2. Cervical Cancer
- 6.3. Anal Cancer
- 6.4. Vaginal Cancer
- 6.5. Vulvar Cancer
- 6.6. Mouth Cancer
- 6.7. Genital Warts
- 6.8. Others
- 7. HUMAN PAPILLOMA VIRUS VACCINE MARKET BY GENDER
- 7.1. Introduction
- 7.2. Male
- 7.3. Female
- 8. HUMAN PAPILLOMA VIRUS VACCINE MARKET BY GEOGRAPHY
- 8.1. North America
- 8.1.1. USA
- 8.1.2. Canada
- 8.1.3. Mexico
- 8.2. South America
- 8.2.1. Brazil
- 8.2.2. Argentina
- 8.2.3. Others
- 8.3. Europe
- 8.3.1. United Kingdom
- 8.3.2. Germany
- 8.3.3. Italy
- 8.3.4. Spain
- 8.3.5. Others
- 8.4. Middle East and Africa
- 8.4.1. Israel
- 8.4.2. Saudi Arabia
- 8.4.3. Others
- 8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. Japan
- 8.6.3. India
- 8.6.4. Australia
- 8.6.5. Others
- 9. COMPETITIVE ENVIRONMENT AND ANALYSIS
- 9.1. Major Players and Strategy Analysis
- 9.2. Emerging Players and Market Lucrativeness
- 9.3. Mergers, Acquisitions, Agreements, and Collaborations
- 9.4. Vendor Competitiveness Matrix
- 10. COMPANY PROFILES
- 10.1. Merck & Co Inc.
- 10.1.1. Overview
- 10.1.2. Products and Services
- 10.1.3 Financials
- 10.1.4. Key Developments
- 10.2. GlaxoSmithKline Plc
- 10.2.1. Overview
- 10.2.2. Products and Services
- 10.2.3 Financials
- 10.3. Sanofi S.A.
- 10.3.1. Overview
- 10.3.2. Products and Services
- 10.3.3 Financials
- 10.3.4. Key Developments
- 10.4. Xiamen Innovax Biotech Co. Ltd. (Innovax)
- 10.4.1. Overview
- 10.4.2. Products and Services
- 10.4.3. Key Developments
- 10.5. Inovio Pharmaceuticals Inc.
- 10.5.1. Overview
- 10.5.2. Products and Services
- 10.5.3. Financials
- 10.5.4. Key Developments
- 10.6. Janssen Pharmaceuticals Inc
- 10.6.1. Overview
- 10.6.2. Products and Services
- 10.6.3. Key Developments
- 10.7. Serum Institute of India Pvt. Ltd.
- 10.7.1. Overview
- 10.7.2. Products and Services
- LIST OF TABLES
- LIST OF FIGURES
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook